SENSEX
NIFTY
GOLD
USD/INR

Weather

image 37    C

Economy News

The Economic Times

Economy / The Economic Times

details

Pharma in her DNA, Wockhardt scion ready for deep dive in the US

Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades without new antibiotics. Zahabiya is focused on hospital penetration, physician advocacy, and demonstrating economic value to healthcare systems.

10 Jun 2026 12:41 am